Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 714 (ZNF714) is a member of the KRAB-containing zinc finger protein family, which constitute one of the largest families of transcription factors in humans. As a zinc finger protein, it is predicted to bind DNA in a sequence-specific manner, likely regulating gene expression at the level of RNA polymerase II-dependent transcription. ZNF714 contains a KRAB domain, usually involved in epigenetic repression, and an array of 14 zinc finger motifs. While definitive protein-level functional studies are sparse, transcriptomic analyses and functional knockdown experiments in cancer cell lines indicate that ZNF714 may influence cellular pathways related to proliferation, migration, invasion, apoptosis, and cell adhesion. ZNF714 is commonly overexpressed in multiple types of tumors, particularly lung cancer, and its expression is associated with immunosuppressive features and oncogenic phenotypes. Despite these associations, the exact molecular mechanisms, clinical significance, and potential as a direct therapeutic target remain to be clarified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 714 (ZNF714).